26 Jun Is it possible to maximize the chances of having a healthy baby?
By Reproclinic Editorial Committee
Having a healthy baby is every parent’s wish. The average age in which the first child is born has increased considerably since the insertion of women into the world of work, this being one of the causes that chromosomal alterations of embryos have increased with them. After reaching the age of 37, the ovules lose quality and from the age of 40 the chances of having a baby with a chromosomal problems multiply.
What options are there for having a healthy baby?
If you are worried about becoming a mom above the age of 37 and that your baby may not be born healthy, do not worry. Thanks to the great medical and technological advances, there are several genetic analysis of embryos and gametes that maximize the chances that your embryo does not suffer from chromosomal alterations. These techniques are:
GENETIC DIAGNOSIS OF EMBRYOS
Method used in IVF treatments where we genetically analyze the embryos before starting the transfer to know which is the most suited.
Through PGD we can detect chromosomal or genetic alterations, such as an embryo being unable to implant in the maternal womb, an embryo being unable to develop (abortion or non-evolving pregnancy), or it being born with Edwards Syndrome or Down Syndrome.
SCREENING OF RECESSIVE DISEASES (GENETIC COMPATIBILITY TEST BETWEEN COUPLES)
In this test we genetically analyze the donors and the recipient woman or couple that performs the treatment. This way, we assign the ideal donor for each recipient and maximize the chances of the child being born without diseases.
We are all healthy carriers of 5-7 genetic mutations that determine that we are healthy carriers of certain recessive genetic diseases. If our partner or donor is a carrier of the same disease, 25% of children who have it will be sick and 50% will be healthy carriers.
To avoid risks, we make a genetically study on the compatibility of donors and partners analyzing more than 300 recessive diseases.
NON-INVASIVE PRENATAL TEST
Through a blood test in the mother during the first weeks of pregnancy, a genetic study called the Non-Invasive Prenatal Test (TIPN) is done where it is studied that there are no diseases in the fetus.
At Reproclinic we maximize your pregnancy chances, reinforcing them by fertility techniques and the newest genetic tests. For us, it’s a very important part of the process to maximize the chances on your baby being born healthy.
If you want more information about our genetic tests, contact us now. First face-to-face visit or Skype Interview is FREE!
We’ll get in touch with you
Do you have questions you need answered? Contact us to request more information or an initial medical appointment, at the clinic or by videoconference. Leave us your contact information, and we’ll call you. Without any waiting lists.
Privacy policy
Before providing the information on this form, and pursuant to RGPD 2016/679, you must read and agree with these conditions on the protection of personal data, accepting and consenting to the processing of your data by Reproclinic sl (Reproclinic) using the methods and for the purposes indicated in this text, in the Data Protection Statement, Privacy Policy, and in the Legal Notice.
About your data
We inform you that your data will be included in a file managed by Reproclinic sl (Reproclinic) in order to reply to your request and send you the information you requested, as well as to send you commercial communications electronically on services that may be of interest to you..
By filling out this application form, you grant your unequivocal consent to Reproclinic sl (Reproclinic), which shall provide us with the legal basis for processing your personal information for the purposes listed in the previous paragraph.
Your information may be transferred to Prolonga Fertilidad sl (Fertty) or to companies with which it has business ties.
You may exercise your rights to Access, Rectify, Delete, Oppose the processing of, Erase, Limit and Portability of your data by writing to Reproclinic C / Ausiàs Marc 25, 08010 Barcelona (lopd@reproclinic.com).
Unless you inform us otherwise, we will assume that your details have not been modified, that you agree to notify us of any change thereto, and that we have your consent to process said details for the aforementioned purposes.
Privacy policy
Before providing the information on this form, and pursuant to RGPD 2016/679, you must read and agree with these conditions on the protection of personal data, accepting and consenting to the processing of your data by Reproclinic sl (Reproclinic) using the methods and for the purposes indicated in this text, in the Data Protection Statement, Privacy Policy, and in the Legal Notice.
About your data
We inform you that your data will be included in a file managed by Reproclinic sl (Reproclinic) in order to reply to your request and send you the information you requested, as well as to send you commercial communications electronically on services that may be of interest to you..
By filling out this application form, you grant your unequivocal consent to Reproclinic sl (Reproclinic), which shall provide us with the legal basis for processing your personal information for the purposes listed in the previous paragraph.
Your information may be transferred to Prolonga Fertilidad sl (Fertty) or to companies with which it has business ties.
You may exercise your rights to Access, Rectify, Delete, Oppose the processing of, Erase, Limit and Portability of your data by writing to Reproclinic C / Ausiàs Marc 25, 08010 Barcelona (lopd@reproclinic.com).
Unless you inform us otherwise, we will assume that your details have not been modified, that you agree to notify us of any change thereto, and that we have your consent to process said details for the aforementioned purposes.
